Recent studies have illuminated the connection between the diabetes medication metformin and weight loss, attributing this effect to an “anti-hunger” molecule, lac-phe, which is also produced following vigorous exercise. This discovery, spearheaded by teams from Stanford Medicine and Harvard Medical School, underscores the significant impact of lac-phe on metabolism, exercise, and appetite regulation, potentially heralding a new era in weight management pharmaceuticals.
Metformin and Weight Loss: Unraveling the Mystery

Metformin, a drug commonly prescribed to manage blood sugar levels in diabetic patients, has been observed to induce moderate weight loss. Researchers at Stanford Medicine and Harvard Medical School have traced this weight-reducing property to the molecule lac-phe, which is produced in the body after intense physical activity. This finding elucidates the previously unclear mechanism behind metformin’s ability to decrease body weight and opens new avenues for understanding how exercise influences hunger and metabolism.
The Role of Lac-Phe in Hunger and Exercise

Lac-phe, a molecule that Stanford researchers discovered in 2022, emerges from the combination of lactate — a muscle fatigue byproduct — and the amino acid phenylalanine. This molecule increases after strenuous exercise, leading to reduced hunger. This discovery was pivotal in linking the metabolic pathways of exercise and metformin, suggesting that both activate similar biological mechanisms to curb appetite.
Clinical Observations and Experiments

In laboratory settings, obese mice administered with metformin showed elevated lac-phe levels and reduced food intake, leading to weight loss. Similar observations were made in humans with type 2 diabetes undergoing metformin treatment, where increased lac-phe levels were consistently recorded. These findings were bolstered by data from a broader study on atherosclerosis, which showed higher lac-phe levels in participants taking metformin, further substantiating the drug’s role in activating this anti-hunger pathway.